Glenmark introduces 3-in-1 inhaler therapy for COPD in India General Announcement Filing viewer · member access Original SGX announcement
Glenmark divests VWash, a female intimate hygiene wash, to Hindustan Unilever General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals & Hikma enter into an Exclusive Licensing Agreement General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement
BM Intimation for Unaudited Financial Results Of Company for 3rd Quarter & 9 Months Ended 31.12.2019 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Deferasirox Tablets for Oral Suspension General Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Metformin Hydrochloride Extended Release Tablets General Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Adapalene and Benzoyl Peroxide Gel, 0.1%|2.5% General Announcement Filing viewer · member access Original SGX announcement
Gpl receives approval from Russian Ministry of Healthcare to mkt Montlezir film-coated tablets General Announcement Filing viewer · member access Original SGX announcement
GPL secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index General Announcement Filing viewer · member access Original SGX announcement
Notice of 41st Annual General Meeting of the Company for FY 2018-19 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Pimecrolimus Cream, 1% General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives approval for combination of Remogliflozin Etabonate and Metformin Hydrochloride General Announcement Filing viewer · member access Original SGX announcement
Credit Rating by Fitch Ratings General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Ranolazine Extended-Release Tablets General Announcement Filing viewer · member access Original SGX announcement
GPL to partner with Novartis to promote,commercialize,distribute 3 respiratory products in Brazil General Announcement Filing viewer · member access Original SGX announcement
FDA Issues Complete Response Letter for Ryaltris - olopatadine hydrochloride and mometasone furoate General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives tentative ANDA approval for Clindamycin Phosphate Foam, 1% General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals Announces Results from a Phase 3 Study of Ryaltris General Announcement Filing viewer · member access Original SGX announcement
GPL appoints Dr. Yasir Rawjee as CEO of Glenmark Life Sciences, its subsidiary for the API business General Announcement Filing viewer · member access Original SGX announcement
Intimation of Appointment of Ms. Saira Ramasastry as an Additional Director - Independent Director General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5% General Announcement Filing viewer · member access Original SGX announcement